Plants on demand

Pharmaceutical Engineering

Volumn 24, Issue 3, 2004, Pages 24-34

  Hall, Donald R ^a  

^a Engineered Technologies Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN; CELECOXIB; FLUCONAZOLE; NEW DRUG; SERTRALINE; SILDENAFIL;

DISEASE MANAGEMENT; DRUG APPROVAL; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE FACILITY; HEALTH MAINTENANCE ORGANIZATION; PHARMACEUTICAL ENGINEERING; PROCESS DEVELOPMENT; PRODUCTIVITY; PROFIT; REVIEW;

EID: 2942530604     PISSN: 02738139     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. As reported by the Pharmaceutical Research and Manufacturers of America (PhRMA).
2. Gilbert, J., Henske, P., and Singh, A., "Rebuilding Big Pharma," In Vivo, Vol. 21, No. 10, Nov 2003.
3. Figures 1, 2, 3, and 4 are excerpted with Permission form Dr. Peter Green, Vice President Pharmaceutical Sciences - Michigan, Pfizer, from a paper entitled, "From a New Chemical Entity to a Marketed Product - The Development Process as Part of the Value Chain," presented at the October 9, 2003 meeting of the Chemist Club, Marketing and Economics Section, New York City.
4. Example provided by William Fox, Sr. Engineering Consultant, Project Development, Indianapolis, IN.
5. Paper presented by Stan Newberger, Principal, CE&IC at winter meeting of ISPE in Tampa, Feb 10-12, 2004 in the Bulk Pharmaceutical Guide Conference.
6. The term "adaptable" instead of flexible is used by William Fox, Sr. Engineering Consultant, Project Development, to describe the inherent ability to add capability, ultimately to the limits of a system or space's masterplan, without compromising functionality or operability. The term flexible, when stated as a project requirement, seems to encourage the inclusion into the initial scope many elements that may not, in the end, be used very frequently and which add cost, clutter and complexity.
7. CII reports on design-build, modular construction and front end loading at www.construction-institute.org.
8. FDA, The Pink Sheet
9. Morgan Stanley, McKinsey analysis.
10. Engineered Technologies Corp.
11. Hovione Corp.